Coenzyme Q10: Clinical update and bioavailability

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 16, Issue 1, 2011, Pages 129-137

  Bank, Ginny ^a   Kagan, Daniel ^b   Madhavi, Doddabele ^b  

^a Full Spectrum Consulting   (United States)

^b BioActives LLC   (United States)

Author keywords

Bioavailability; Cardiovascular diseases; Coenzyme Q10; CoQ10; Neurodegenerative disorders; Periodontal disease; Reproductive health

Indexed keywords

EID: 79957934382     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Kalen A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24: 579-584.
2. Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 in cardiac disease, hypertension and meniere-like syndrome. Pharmacol Ther. 2009;124:259-268.
3. Yamagami T, Shibata N, Folkers K. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension. Res Commun Chem Pathol Pharmacol. 1975;11:273-288.
4. Shults CW, Haas RH, Passov D, Beal MF. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neu-rol. 1997;42:261-264.
5. Thorne Research, Inc. Coenzyme Q10. Monograph. Altern Med Rev. 2007;12:159-168.
6. Littarru GP, Nakamura R, Ho L, Folkers K, Kuzell WC. Deficiency of coenzyme Q10 in gingival tissue from patients with per-iodontal disease. Proc Natl Acad Sci U S A. 1971;68:2332-2335.
7. Nakamura R, Littarru G, Folkers K, Wilkinson EG. Deficiency of coenzyme Q in gingival of patients with periodontal disease. Int J Vitam Res. 1973;43:84-92.
8. Gadzik F, Gvozdjakova A, Nadvornikova R, et al. Decreased levels of coenzyme Q10 in patients with bronchial asthma. Allergy. 2002;57:811-814.
9. Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. Biochem Biophys Res Commun. 1988;153:888-896.
10. Goli AK, Goli SA, Byrd RP, Roy TM. Simvastatin-induced lactic acidosis: a rare adverse reaction? Clin Pharmacol Ther. 2002;72: 461-464.
11. Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G. Coen-zyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets. 2010;11:111-121.
12. Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7(suppl):S78-S88.
13. Galpern WR, Cudkowicz ME. Coenzyme Q treatment of neurode-generative diseases of aging. Mitochondrion. 2007;7(suppl): S146-S153.
14. Spindler M, Beal MF, Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009;5: 597-610.
15. Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010;26:250-254.
16. The Huntington Study Group. Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. Mov Disord. 2010;25:1924-1928.
17. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev. 2009;(4):CD007435.
18. Wyman M, Leonard M, Moreledge T. Coenzyme Q10: a therapy for hypertension and statin-induced myalgia? Cleve Clin J Med. 2010;77:435-442.
19. Schaars CF, Stalenhoef AF. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. Curr Opin Lipidol. 2008;19: 553-557.
20. Langsjoen PH, Littaru GP, Silver MA. Potential role of concomitant coenzyme Q10 with statins for patients with hyperlipidemia. Curr Top Nutr Res. 2005;3:149-158.
21. McMurray JJ, Dunselman P, Wedel H, et al. Coenzyme Q10, rosu-vastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010;56:1196-1204.
22. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol. 2007;49:2231-2237.
23. Abdul-Rasheed OF, Farid YY, Al-Nasiri US. Coenzyme Q10 and oxidative stress markers in seminal plasma of Iraqi patients with male infertility. Saudi Med J. 2010;31:501-506.
24. Balercia G, Mancini A, Paggi F, et al. Coenzyme Q10 and male infertility. J Endocrinol Invest. 2009;32:626-632.
25. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182:237-248.
26. Roland L, Gagne A, Belanger MC, et al. Existence of compensatory defense mechanisms against oxidative stress and hypertension in pre-eclampsia. Hypertens Pregnancy. 2010;29:21-37.
27. Teran E, Racines-Orbe M, Vivero S, Escudero C, Molina G, Calle A. Pre-eclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Radic Biol Med. 2003;35:1453-1456.
28. Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009;32:185-190.
29. Zhao X, Li L, Wang Z. Chemoprevention of breast cancer: current status and future prospects. Front Biosci. 2006;11:2249-2256.
30. Nicolson GL, Conklin KA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis. 2008; 25:161-169.
31. Sachdanandam P. Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy. Biofactors. 2008;32:151-159.
32. Hertz N, Lister RE. Improved survival in patients with end-stage cancer treated with coenzyme Q10 and other antioxidants: a pilot study. J Int Med Res. 2009;37:1961-1971.
33. Chai W, Cooney RV, Franke AA, et al. Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19: 2351-2356.
34. Folkers K. A critique of 25 years of research which culminated in the successful therapy of periodontal disease with coenzyme Q10. J Dent Health. 1992;42:258-263.
35. Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K. Effect of topical application of coenzyme Q10 on adult periodontitis. Mol Aspects Med. 1994;15(suppl):241-248.
36. Babbush CA, Kagan D, Madhavi D, et al. The efficacy of Perfect Smile toothpaste containing coenzyme Q10-b-cyclodextrin inclusion complex in reducing mild to moderate gingivitis. Natural Med J. 2010;2:16-20.
37. Singh RB, Niaz MA, Kumar A, Sindberg CD, Moesgaard S, Littarru GP. Effect on absorption and oxidative stress of different oral coenzyme Q10 dosages and intake strategy in healthy men. Biofactors. 2005;25:219-224.
38. Joshi SS, Sawant SV, Shedge A, Halpner AD. Comparative bioa-vailability of two novel coenzyme Q10 preparations in humans. Int J Clin Pharmacol Ther. 2003;41:42-48.
39. Kurowska EM, Dresser G, Deutsch L, Bassoo E, Freeman DJ. Relative bioavailability and antioxidant potential of two coen-zyme Q10 preparations. Ann Nutr Metab. 2003;47:16-21.
40. Molyneux S, Florkowski C, Lever M, George P. The bioavailabil-ity of coenzyme Q10 supplements available in New Zealand differs markedly. N Z Med J. 2004;17:U1108.
41. Ullmann U, Metzner J, Schulz C, Perkins J, Leuenberger B. A new coenzyme Q10 tablet-grade formulation (all-Q10) is bioequi-valent to Q-Gel and both have better bioavailability properties than Q-Sorb. J Med Food. 2005;8:397-400.
42. Schultz C, Obermüler-Jevic UC, Hasselwander O, Bernhardt J, Biesalski HK. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10). Int J Food Sci Nutr. 2006;57:546-555.
43. Constantinescu R, McDermott MP, Dicenzo R, et al. A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone). J Clin Pharmacol. 2007;47: 1580-1586.
44. Zmitek J, Smidovnik A, Fir M, et al. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann Nutr Metab. 2008;52:281-287.
45. Liu ZX, Artmann C. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern Ther Health Med. 2009;15:42-46.
46. Ozaki A, Muromachi A, Sumi M, Sakai Y, Morishita K, Okamoto T. Emulsification of coenzyme Q10 using gum arabic increases bioavailability in rats and human and improves food processing stability. J Nutr Sci Vitaminol (Tokyo). 2010;56: 41-47.
47. Madhavi D, Kagan D. A study on the bioavailability of a novel sustained-release coenzyme Q10-b-cyclodextrin complex. J Integr Med. 2010;9:20-24.
48. Kagan D, Madhavi D, Bank G, et al. "Universal" and "reliable" bioavailability claims: criteria that may increase physician confidence in nutritional supplements. Natural Med J. 2010;2: 1-5.